-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
BeyondSpring (NASDAQ:BYSI) Shares Up 0.7%
BeyondSpring (NASDAQ:BYSI) Shares Up 0.7%
BeyondSpring Inc. (NASDAQ:BYSI – Get Rating)'s share price shot up 0.7% during trading on Monday . The stock traded as high as $1.57 and last traded at $1.52. 165,615 shares traded hands during trading, a decline of 59% from the average session volume of 403,071 shares. The stock had previously closed at $1.51.
BeyondSpring Stock Performance
The company has a market capitalization of $57.23 million, a PE ratio of -0.88 and a beta of 1.04. The firm has a fifty day moving average of $1.52 and a two-hundred day moving average of $1.94.
Get BeyondSpring alerts:Institutional Investors Weigh In On BeyondSpring
Several institutional investors have recently bought and sold shares of BYSI. Walleye Capital LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $28,000. Mirabella Financial Services LLP purchased a new stake in BeyondSpring during the 1st quarter valued at about $44,000. Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring during the 2nd quarter valued at about $44,000. Fox Run Management L.L.C. purchased a new stake in BeyondSpring during the 4th quarter valued at about $56,000. Finally, Acadian Asset Management LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $76,000. 18.89% of the stock is currently owned by hedge funds and other institutional investors.
About BeyondSpring
(Get Rating)BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
Featured Stories
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- Workhorse Group Is Ready To Get Back On The Horse
- Are 3M, Honeywell, GE Buys After Quarterly Reports?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
BeyondSpring Inc. (NASDAQ:BYSI – Get Rating)'s share price shot up 0.7% during trading on Monday . The stock traded as high as $1.57 and last traded at $1.52. 165,615 shares traded hands during trading, a decline of 59% from the average session volume of 403,071 shares. The stock had previously closed at $1.51.
纳斯达克周一盘中股价飙升0.7%,盘中一度涨至1.57美元,最新报1.52美元。当日有165,615股股票易手,较403,071股的日均成交量下跌59%。此前该股收盘价为1.51美元。
BeyondSpring Stock Performance
万春医药股票表现
The company has a market capitalization of $57.23 million, a PE ratio of -0.88 and a beta of 1.04. The firm has a fifty day moving average of $1.52 and a two-hundred day moving average of $1.94.
该公司市值为5723万美元,市盈率为-0.88,贝塔系数为1.04。该公司的50日移动均线切入位在1.52美元,200日移动均线切入位在1.94美元。
Institutional Investors Weigh In On BeyondSpring
机构投资者在万春医药上发表看法
Several institutional investors have recently bought and sold shares of BYSI. Walleye Capital LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $28,000. Mirabella Financial Services LLP purchased a new stake in BeyondSpring during the 1st quarter valued at about $44,000. Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring during the 2nd quarter valued at about $44,000. Fox Run Management L.L.C. purchased a new stake in BeyondSpring during the 4th quarter valued at about $56,000. Finally, Acadian Asset Management LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $76,000. 18.89% of the stock is currently owned by hedge funds and other institutional investors.
几家机构投资者最近买卖了比亚迪的股票。Walleye Capital LLC在第一季度购买了万春医药的新股份,价值约28,000美元。米拉贝拉金融服务有限责任公司在第一季度购买了万春医药的新股份,价值约44,000美元。猎户座投资组合解决方案有限责任公司在第二季度购买了万春医药的新股份,价值约44,000美元。狐狸奔跑管理有限公司在第四季度购买了万春医药的新股份,价值约56,000美元。最后,阿卡迪亚资产管理有限责任公司在第一季度购买了万春医药的新股份,价值约76,000美元。18.89%的股票目前由对冲基金和其他机构投资者持有。
About BeyondSpring
关于万春医药
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
万春医药是一家临床期生物制药公司,与其子公司一起专注于癌症疗法的开发。该公司的主要资产是普利布林,这是一种选择性免疫调节微管结合剂,已经完成了预防化疗引起的中性粒细胞减少症和治疗晚期非小细胞肺癌的第三阶段临床试验。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- Workhorse Group Is Ready To Get Back On The Horse
- Are 3M, Honeywell, GE Buys After Quarterly Reports?
- 在新浪万春医药上免费获取斯托克新闻网的研究报告
- 投资石油股票的方式和原因
- 投资黄金股票的方式和原因
- DraftKings,Inc.的圆底开始逆转
- 工作马集团准备重返赛马
- 3M、霍尼韦尔、通用电气在季度报告后收购吗?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
接受万春医药日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对万春医药及相关公司评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧